Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
16 04 2021
Historique:
received: 07 08 2019
accepted: 18 03 2021
entrez: 17 4 2021
pubmed: 18 4 2021
medline: 4 5 2021
Statut: epublish

Résumé

Narcolepsy type 1 (NT1) is a chronic neurological disorder having a strong association with HLA-DQB1*0602, thereby suggesting an immunological origin. Increased risk of NT1 has been reported among children or adolescents vaccinated with AS03 adjuvant-supplemented pandemic H1N1 influenza A vaccine, Pandemrix. Here we show that pediatric Pandemrix-associated NT1 patients have enhanced T-cell immunity against the viral epitopes, neuraminidase 175-189 (NA

Identifiants

pubmed: 33863907
doi: 10.1038/s41467-021-22637-8
pii: 10.1038/s41467-021-22637-8
pmc: PMC8052463
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
CD4 Antigens 0
Epitopes, T-Lymphocyte 0
HLA-DQ beta-Chains 0
HLA-DQB1 antigen 0
Influenza Vaccines 0
Viral Proteins 0
pandemrix 0
Mannosyltransferases EC 2.4.1.-
protein O-mannosyltransferase EC 2.4.1.109
NA protein, influenza A virus EC 3.2.1.18
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2283

Références

Nature. 2018 Oct;562(7725):63-68
pubmed: 30232458
Nat Biotechnol. 2017 Oct 11;35(10):908-911
pubmed: 29020005
Tissue Antigens. 2000 Nov;56(5):446-8
pubmed: 11144293
Brain. 2010 May;133(Pt 5):1300-11
pubmed: 20403960
Nat Genet. 2009 Jun;41(6):708-11
pubmed: 19412176
Sleep Med Rev. 2012 Dec;16(6):539-45
pubmed: 22465566
J Immunol. 2006 Jun 15;176(12):7715-25
pubmed: 16751419
Mutat Res. 2018 Oct - Dec;778:45-50
pubmed: 30454682
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12323-E12332
pubmed: 30541895
Nat Genet. 2011 Jan;43(1):66-71
pubmed: 21170044
FEBS Lett. 2011 Dec 1;585(23):3758-63
pubmed: 21910991
Bioinformatics. 2007 May 15;23(10):1289-91
pubmed: 17379693
Neurology. 1998 Apr;50(4):1149-52
pubmed: 9566413
Nat Commun. 2019 Nov 20;10(1):5247
pubmed: 31748512
Sleep. 2016 Mar 01;39(3):581-7
pubmed: 26518595
EBioMedicine. 2018 Mar;29:47-59
pubmed: 29449194
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Nat Med. 2000 Sep;6(9):991-7
pubmed: 10973318
J Neuroimmunol. 2019 Jul 15;332:167-175
pubmed: 31048269
Front Immunol. 2018 Nov 21;9:2701
pubmed: 30519244
PLoS One. 2012;7(3):e33536
pubmed: 22470453
Gastroenterology. 2020 May;158(6):1667-1681.e12
pubmed: 32032584
Tissue Antigens. 1999 Aug;54(2):138-45
pubmed: 10488740
Lancet Neurol. 2015 Mar;14(3):318-28
pubmed: 25728441
Nat Methods. 2015 May;12(5):380-1
pubmed: 25924071
Lancet. 2007 Feb 10;369(9560):499-511
pubmed: 17292770
PLoS Comput Biol. 2015 Nov 25;11(11):e1004503
pubmed: 26606115
Nucleic Acids Res. 2016 Jul 8;44(W1):W147-53
pubmed: 27190236
Sleep. 1997 Nov;20(11):1012-20
pubmed: 9456467
Nucleic Acids Res. 2012 Aug;40(15):e115
pubmed: 22730293
Lancet Infect Dis. 2014 Mar;14(3):227-38
pubmed: 24360892
J Clin Virol. 2019 Oct;119:44-52
pubmed: 31491709
Sleep Med Rev. 2018 Apr;38:177-186
pubmed: 28847694
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Hum Immunol. 2014 Jan;75(1):65-70
pubmed: 24055898
Nat Rev Immunol. 2006 Apr;6(4):271-82
pubmed: 16557259
Diabetologia. 1998 Nov;41(11):1293-7
pubmed: 9833935
PLoS One. 2014 Dec 15;9(12):e114361
pubmed: 25501681
PLoS Genet. 2013 Oct;9(10):e1003880
pubmed: 24204295
N Engl J Med. 2015 Dec 31;373(27):2654-62
pubmed: 26716917
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Bioinformatics. 2017 Sep 1;33(17):2774-2775
pubmed: 28481966
Bioinformatics. 2006 Nov 15;22(22):2825-7
pubmed: 16982708
Am J Hum Genet. 2015 Jan 8;96(1):136-46
pubmed: 25574827
Lancet Neurol. 2014 Jun;13(6):600-13
pubmed: 24849861

Auteurs

A Vuorela (A)

Clinicum, University of Helsinki, Helsinki, Finland.

T L Freitag (TL)

Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland. tobias.freitag@helsinki.fi.
Translational Immunology Research Program, University of Helsinki, Helsinki, Finland. tobias.freitag@helsinki.fi.

K Leskinen (K)

Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.

H Pessa (H)

Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.

T Härkönen (T)

Clinicum, University of Helsinki, Helsinki, Finland.

I Stracenski (I)

Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.

T Kirjavainen (T)

Children's Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.

P Olsen (P)

Department of Child Neurology, Oulu University Hospital, Oulu, Finland.

O Saarenpää-Heikkilä (O)

Department of Pediatrics, Tampere University Hospital, Tampere, Finland.

J Ilonen (J)

Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Clinical Microbiology, Turku University Hospital, Turku, Finland.

M Knip (M)

Clinicum, University of Helsinki, Helsinki, Finland.
Children's Hospital, University of Helsinki, and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland.

A Vaheri (A)

Department of Virology, University of Helsinki, Helsinki, Finland.

M Partinen (M)

Clinicum, University of Helsinki, Helsinki, Finland.
Department of Neurosciences, University of Helsinki, Helsinki, Finland.
Helsinki Sleep Clinic, Vitalmed Research Center, Helsinki, Finland.

P Saavalainen (P)

Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.

S Meri (S)

Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.
Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.

O Vaarala (O)

Clinicum, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH